Member Info for substp

PIHL Equity on June 9th 2006 owned 12,412,237 shares in HCEG . At 9 June 2006 NW Wray had an interest in 3,010,017 ordinary shares of the Company. PIHL Equity LLP, an entity in which NW Wray is entitled to exercise more than one third of the voting power at general meetings, held 12,412,237 ordinary shares. Therefore at 9 June 2006 NW Wray was interested, directly and indirectly, in 15,422,254 ordinary shares of the Company PIHL Equity LLP, an entity in which N Leslau is entitled to exercise more than one third of the voting power at general meetings, held 12,412,237 ordinary shares and therefore N Leslau was interested, indirectly, in 12,412,237 ordinary shares of the Company at 9 June 2006. http://www.hcegroup.com/download/3480/Annual%20Report%202006.pdf

PIHL Equity on June 9th 2006 owned 12,412,237 shares in HCEG . At 9 June 2006 NW Wray had an interest in 3,010,017 ordinary shares of the Company. PIHL Equity LLP, an entity in which NW Wray is entitled to exercise more than one third of the voting power at general meetings, held 12,412,237 ordinary shares. Therefore at 9 June 2006 NW Wray was interested, directly and indirectly, in 15,422,254 ordinary shares of the Company PIHL Equity LLP, an entity in which N Leslau is entitled to exercise more than one third of the voting power at general meetings, held 12,412,237 ordinary shares and therefore N Leslau was interested, indirectly, in 12,412,237 ordinary shares of the Company at 9 June 2006. http://www.hcegroup.com/download/3480/Annual%20Report%202006.pdf

PUBLIC REPORT SUBJECT: Proposed registration affecting the above listed products DESCRIPTION OF PROPOSED ACTION: The Director of Pesticide Regulation proposes to register the products listed above pursuant to Chapter 2 of Division 7 (beginning with Section 12751 of the Food and Agriculture Code) after Date April 17, 2007. Comments concerning this proposed action may be directed to the Department of Pesticide Regulation's Pesticide Registration Branch until that date. As a result of scientific evaluation, it has been determined that no direct or indirect significant adverse environmental impact is anticipated from the registration of the above listed products; therefore, no public report on the individual products will be filed. http://www.cdpr.ca.gov/docs/nod/2007-11.htm

Notice of Proposed and Final Decisions and Directors Findings Volume 2007-11 March 19, 2007 Department of Pesticide Regulation Pesticide Registration Branch POST THROUGH * April 17, 2007 NOTICE OF PROPOSED DECISIONS TO REGISTER PESTICIDE PRODUCTS The Director of the Department of Pesticide Regulation, pursuant to Section 6253 (Title 3) of the California Code of Regulations, notices the Department's following proposed decisions to register pesticide products. Interested persons may comment on these proposed decisions up to and including the date shown in the top line of this Notice to the Pesticide Registration Branch, Department of Pesticide Regulation, P.O. Box 4015 Sacramento, California 95812 4015. Contacts regarding this notice should be made to the Pesticide Registration Branch at (916) 445 4400. Notice of Proposed Decisions to Register (Continued) Page 3 Tracking Number EPA Registration Number Applicant / Brand Name 218961 - (NO NUMBER ASSIGNED) EBIOX LTD EBIOX TRUKLEEN WIPES USE: ANTIMICROBIAL - FOR THE CONTROL OF ORGANISMS SUCH AS SALMONELLA CHOLERAESUIS, HIV, AND PSEUDOMONAS AERUGINOSA ON HARD, NON-POROUS SURFACES TYPE: SECTION 3 REGISTRATION - ACTIVE INGREDIENT(S): ALKYL (50%C12, 30%C14, 17%C16, 3%C18) DIMETHYLBENZYL AMMONIUM CHLORIDE DIDECYL DIMETHYL AMMONIUM CHLORIDE POLYHEXAMETHYLENE BIGUANIDINE CAS NUMBER(S): 63449-41-2 , 126851-24-9 , 154765-32-9 , 7173-51-5 , 32289-58-0 , 82500-57-0

Great Storm ! You ordered it on Thurs. and received it on Sat. , not bad . And you are pleased with the product . :-)

Another area that we tend to overlook and could be huge in the US. 26.May.2004 Ebiox launch into the veterinary market "with plans to launch in the US in Autumn following Environment Protection Agency approval" “As our dental business has grown in both domestic and international markets as well as endoscope reprocessing, hospital supply and veterinary supply, we believe the new name better reflects our current and future activities in the markets we serve,” said Carey Lyons, Executive Vice President. Lyons continued, “The new name will also eliminate any confusion caused by our acquisition of Sultan Dental Products.” In the UK : http://tinyurl.com/2xa2es

This is the first time I've ever seen the Ultra range ( Instrument Cleaners )in a catalogue with the prices . If you back track it , it appears the site is still active : Leeds Teaching Hospital http://tinyurl.com/2mudj2 http://browse.uk-plc.net/indexalpha.htm

It's ongoing . Someone has been paying the fees ! Publication info: EP1761285 A1 - 2007-03-14 "Abstract of WO2005123147 Ductwork used for the supply of potable water in dental surgeries is prone to undesirable build up of biofilm and associated bacteria. These may be combated effectively by applying to the ductwork a composition comprising: a metal silicate or silicate complex; a metal phosphate or polyphosphate or orthophosphoric acid; and a non-ionic or amphoteric surfactant." http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=EP1761285&F=8 Click on "View document in the European Register" http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2005123147&F=8

Thanks for all of the effort Storm . Who knows one day it may end up on their shelves and many others like them , I hope .

Great stuff Storm !!! Be looking forward to hearing from you on the stores and product . :-)

This site has a store locator ! Is the Ebiox products being offered in the shops now ? http://www.keepable.co.uk/modules/shop/view.asp?catid=20&Prodcode=SU2000/014783

Storm , they use to be on the Ebiox Distribution Partner page . You can find info on them in old HCEG RNSs . http://www.mmsmedical.com/

I see Optiscope has received its patent from Taiwan : http://tinyurl.com/375xbu Still moving forward !

This with the fact that MMS has now disappeared off the Ebiox web site makes me think that the ball is truly starting to roll with Sultan.

Think someone is gearing up for something big : http://tinyurl.com/yuunu6 http://tinyurl.com/2ulafa AS well as the the other two that we've already seen : QC Chemist QC Lab Manager

Hi Pat . Investors Chronicle

Hi Storm . This was completely inspired by someone else on another board . I just posted it .

In first aid, costs, capital spending, and working capital requirements have all been cut, and the business has been relaunched under the Crest Medical brand. But progress from Ebiox has been even more impressive. A $4.5m (£2.3m) distribution agreement for the dental sector in Europe, Latin America, Asia and Africa was signed in January and, in February, the product won approval from the US Environment Protection Agency. This clears the way for the company to seek approval from US state regulators, following which it can start to market the product." END IC does say that the cos on their list are not guaranteed to recover, and may have further problems, but that they are showing promising signs of addressing the problems that bought them low in the first place. I should say that I did contact IC several weeks ago pointing out that HCEG was showing signs of recovery, and had made good progress with Ebiox. I hope my small effort helped focused attention on this fallen star, and which I feel has a good chance of recovering further. It will be interesting to see if ICs coverage has any effect whatsoever - who knows!

From someone on another board : IC has an article called 'Fighing back', and looks at AIM cos that have issued profit warnings, and where their SPs have been hammered. They have a list of cos. that are 'fighting back', and HCEG is one o the cos that they suggest looking at, and this is what they say: "Healthcare Enterprise Group Share price: 6p PE ratio: na Share-price fall since one-year peak: 63 per cent What went wrong: Healthcare Enterprise Group had looked like an exciting prospect. It had a stable, well-established business supplying first-aid products and another, more exciting, business developing new products, such as Ebiox, a disinfectant for hospitals. Last year, however, problems began to develop in both parts of the group. The first-aid operation struggled to integrate acquisitions and it also lost a major contract with the police. Meanwhile, in the new products business, US approval for Ebiox was delayed, and there were disappointing results from Fertiligent, a sperm pump to help couples with fertility problems. What's changed: Since last November's first-half results, there have been a number of encouraging changes. The group's management has been strengthened and, on the financing front, it raised £2m in a placing and agreed a further £2m financing facility. There have also been improvements in the operating businesses. In first aid, costs, capital spending, and working capital requirements have all been cut, and the b

Be a Great place for the "Ebiox Ultra" and "Trionic" range !